WPP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
WPP is not a good buy right now for an impatient investor. The chart remains in a clear downtrend (bearish moving-average stack) and there are no Intellectia buy signals to justify stepping in aggressively. While options positioning is bullish-leaning and momentum selling is easing, the setup still lacks a confirmed reversal—so buying now is more of a catch-the-falling-knife trade than a high-conviction entry.
Trend is bearish: SMA_200 > SMA_20 > SMA_5 confirms a sustained downtrend. Momentum: MACD histogram is negative (-0.166) but contracting, suggesting downside momentum is weakening (early stabilization attempt, not a reversal yet). RSI(6)=35.87 is weak/near-oversold territory but not a strong buy trigger by itself. Key levels: price 20.88 sits below pivot 21.337; near support S1=20.536 (then S2=20.042). A quick tactical bounce is possible if S1 holds, but a higher-probability buy would require reclaiming the pivot (21.337) and then holding above it toward R1=22.137.
Intellectia Proprietary Trading Signals:
Options market positioning is call-heavy (bullish skew) and downside momentum is easing (MACD histogram contracting). Price is also near a defined support zone (S1 ~20.536), which can attract dip buyers. Recent news includes a partnership (Moyom Biotechnology x WPP) to support global brand positioning—positive but likely modest in financial impact.
Primary issue is technical: the stock remains in a confirmed downtrend (bearish MA stack) and is below the pivot level, meaning rallies can fail. Analyst actions have been negative on price targets recently, reinforcing a cautious outlook. Elevated implied volatility also suggests uncertainty and can coincide with choppy or risk-off price action.
No usable financial snapshot was provided (data error), so latest-quarter growth trends and quarter/seasonality cannot be assessed from the supplied data.
Recent analyst changes are mildly negative: Morgan Stanley (2026-01-09) cut PT to 365 GBp from 410 GBp, maintained Equal Weight; JPMorgan (2025-12-10) cut PT to 350 GBp from 360 GBp, maintained Neutral. Wall Street view is effectively 'not a buy': ratings are neutral/equal-weight and targets are being lowered, implying limited near-term upside conviction.
